• Cardiovascular Disease
    • Physician at Brigham and Women's Hospital and Harvard Medical School
    Dr. Cannon is a professor of medicine at Harvard Medical School, and senior physician in the Cardiovascular Division at Brigham and Women’s Hospital. He earned his MD from Columbia University College of Physicians and Surgeons in New York and did internal medicine residency at Columbia Presbyterian Medical Center, and cardiovascular fellowship at Brigham and Women’s Hospital. Dr. Cannon has published over 1000 original articles, reviews, or electronic publications in the field of acute coronary syndromes and prevention and has authored or edited 17 books. He has received numerous awards, including leadership awards from the American College of Cardiology and the American Heart Association. As a senior investigator of the TIMI Study Group, he has been principal investigator of more than 15 multicenter clinical trials, including TACTICS-TIMI 18 and PROVE IT, and the IMPROVE IT trial. Dr. Cannon now serves as Executive Director of Cardiometabolic Trials at the Harvard Clinical Research Institute (HCRI). He is leading the RE-DUAL PCI trial, studying novel anticoagulant strategies in patients with atrial fibrillation undergoing stenting, and collaborates on many other trials and registry projects in the fields of acute coronary syndromes, atrial fibrillation, diabetes, lipids and prevention.
    • Cardiovascular Disease
    • Internal Medicine
    • Interventional Cardiology
    • Advanced Techniques in Peripheral Intervention
    • Advanced Techniques in Cerebral Intervention
    • Advanced Techniques in Cardiac Intervention
    • Preventive Cardiology
    • Acute Coronary Syndrome
    Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
    Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart & Vascular Center
    Deepak L. Bhatt MD, MPH, FACC, FAHA, FSCAI, FESC, is Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School. He is also a Senior Physician at Brigham and Women’s Hospital and a Senior Investigator in the TIMI Study Group. After graduating as valedictorian from the Boston Latin School, Dr. Bhatt obtained his undergraduate science degree as a National Merit Scholar at the Massachusetts Institute of Technology while also serving as a research associate at Harvard Medical School. He received his medical doctorate from Cornell University. He completed a Master in Public Health with a concentration in clinical effectiveness at Harvard University. His internship and residency in internal medicine were performed at the Hospital of the University of Pennsylvania, and his cardiovascular training was at Cleveland Clinic. He also completed fellowships in interventional cardiology and cerebral and peripheral vascular intervention as well as serving as Chief Interventional Fellow at Cleveland Clinic, where he spent several years as an interventional cardiologist and an Associate Professor of Medicine. He served for many years as Director of the Interventional Cardiology Fellowship and as Associate Director of the Cardiovascular Medicine Fellowship. He also served as Associate Director of the Cleveland Clinic Cardiovascular Coordinating Center. He was then recruited to be the Chief of Cardiology at VA Boston Healthcare System and served in that role for several years. Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2016. He was selected by Brigham and Women’s Hospital as the 2014 Eugene Braunwald Scholar. Dr. Bhatt’s research interests include acute coronary syndromes, preventive cardiology, and advanced techniques in cardiac, cerebral, and peripheral intervention. He has authored or co-authored over 750 publications and is listed as a Thomson Reuters Highly Cited Researcher. He is the Editor of Cardiovascular Intervention: A Companion to Braunwald’s Heart Disease and Atherothrombosis in Clinical Practice published by Oxford University Press. He was the international PI for the CHARISMA and CRESCENDO trials and co-PI of the three CHAMPION trials. He served as chair of COGENT and helped lead STAMPEDE. He serves as co-chair of the REACH registry and chairs REDUCE-IT. He is co-PI of SAVOR-TIMI 53, SYMPLICITY HTN-3, and THEMIS. In 2014, he was listed in the AHA/ASA top ten advances in heart disease and stroke research (for STAMPEDE and SYMPLICITY HTN-3). He is the Chair of the AHA-GWTG Quality Oversight Committee. He is a Trustee of the ACC. He is Senior Associate Editor for News and Clinical Trials for He is the Editor of the peer-reviewed Journal of Invasive Cardiology, Chief Medical Editor of Cardiology Today’s Intervention for healthcare professionals, and Editor-in-Chief of the Harvard Heart Letter for patients.
    • Cardiovascular Disease
    • Professor of Medicine and Cardiology, Head of the Division of Clinical Electrophysiology at J.W. Goethe University

    Dr. Hohnloser holds a position as professor of medicine and cardiology at the J. W. Goethe University in Frankfurt, Germany, where he serves as the head of the division of clinical electrophysiology. His primary research interests focus on risk stratification for and prevention of sudden cardiac death, and pharmacological, antithrombotic, and interventional therapies of atrial fibrillation. Dr. Hohnloser has served as principal investigator or member of the steering committee of many international large randomized clinical trials related to contemporary issues in clinical arrhythmology. He has coauthored almost 400 publications in peer-reviewed journals, 450 abstracts and 50 book chapters. Dr. Hohnloser has been or is currently serving on several committees of the European Society of Cardiology, The European Heart Rhythm Association, and the Heart Rhythm Society.